Arena Pharmaceuticals will cut its U.S. workforce by approximately 80 employees or 35%, which Arena estimates will reduce annualized cash expenditures for personnel by approximately $11 million. In addition, Arena plans to implement more cuts at its Swiss manufacturing facility, Arena Pharmaceuticals GmbH. The company says the cuts come as it shifts its focus on the advancement of its research and development priorities. Arena says it intends to focus on its key strengths by concentrating ...